Revvity | PKI - Assets


Revvity reported $12B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Agilent USD 13.07B 252M Mar/2026
Align Technology USD 6.31B 80.48M Mar/2026
Bio Techne USD 2.55B 27.9M Mar/2026
Bio-Rad Laboratories USD 9.79B 786.5M Mar/2026
Bruker USD 6.13B 110.7M Mar/2026
Celltrion KRW 759.44B 20.32T Dec/2025
Charles River Laboratories USD 7.73B 594.89M Mar/2026
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Danaher USD 83.54B 80M Mar/2026
Dentsply International USD 5.23B 200M Mar/2026
Deva Holding AS TRY 12.93B 1.83B Sep/2023
Dianthus Therapeutics USD 1.25B 715.96M Mar/2026
Divis Laboratories Ltd INR 200.33B 18.82B Mar/2026
Edwards Lifesciences USD 13.32B 376M Mar/2026
Illumina USD 6.56B 85M Mar/2026
Intuitive Surgical USD 20.11B 347.7M Mar/2026
IQVIA Holdings USD 29.68B 269M Mar/2026
Kangmei Pharma CNY 13.31B 375.64M Mar/2026
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Laboratory Of America USD 19.09B 694.4M Mar/2026
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 63.57M 2.83M Dec/2025
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Mettler Toledo International USD 3.67B 43.73M Mar/2026
Myriad Genetics USD 673.7M 32.9M Mar/2026
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025
OraSure Technologies USD 379.17M 24M Mar/2026
Organigram Holdings CAD 530.67M 31.54M Dec/2025
Ovoca Bio EUR 1.66M 9.75M Jun/2025
Pacific Biosciences Of California USD 782.36M 1.72M Mar/2026
Pharma Mar EUR 385.26M 9.82M Mar/2026
Qiagen NV USD 6.3B 257.54M Dec/2025
Quest Diagnostics USD 16.67B 448M Mar/2026
Quidel USD 5.63B 140.6M Mar/2026
Repligen USD 2.93B 18.93M Mar/2026
Revvity USD 12B 171.82M Mar/2026
Sartorius EUR 9.87B 154.9M Mar/2026
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Tilray USD 2.1B 15.95M Sep/2025
Waters USD 24.53B 19.45B Mar/2026
Zealand Pharma A/S 15.95B 848.45M Dec/2025
Zz Pientze Pharmaceu CNY 18.38B 905.93M Mar/2026